Concentra initiated with a Buy at BofA

BofA analyst Joanna Gajuk initiated coverage of Concentra with a Buy rating and $30.50 price target. The firm identifies Concentra as the largest operator of occupational medicine and onsite clinics in the U.S. and likes its scale with 701 clinics and 20% market share, as well as its unique payor mix with only 1% government exposure and mid-single digits organic growth, the analyst tells investors.